Explore Publications

Prince Bandar, the head of the Saudi national security council, and son of the crown prince, was alleged in court to be the man behind the threats to hold back information about suicide bombers and terrorists. He faces accusations that he himself took more than £1bn in secret payments from the arms company BAE.

Klaus Zumwinkel, the CEO of former German postal monopoly Deutsche Post, is under investigation for tax evasion.

A Chinese facility that hasn't been inspected by the U.S. Food and Drug Administration made the active ingredient in much of the widely used Baxter International Inc. blood-thinner that is under investigation after reports of hundreds of allergic reactions and four deaths among the drug's users, the agency said yesterday.

Dueling reports released yesterday -- one by a consortium largely funded by the biotech industry and the other by a pair of environmental and consumer groups -- came to those diametrically different conclusions.

Comcast said yesterday that it purposely slows down some traffic on its network, including some music and movie downloads, an admission that sparked more controversy in the debate over how much control network operators should have over the Internet.

The president's remarks came the morning after the Senate handed the White House a major victory by voting to broaden the government's spy powers and to give legal protection to phone companies that cooperated in President Bush's program of eavesdropping without warrants.

Just in time for Valentine's Day, five of the leading U.S. jewellers have sworn off gold that someday could come from the Pebble Mine, a huge deposit being scoped out by a subsidiary of a Canadian company near the world's most productive wild sockeye salmon stream in southwestern Alaska.

Staples Inc, the largest U.S. office supplies retailer, said on Friday it ceased doing business with Asia Pulp & Paper (APP) late last month because of environmental concerns.

A Congressional investigation revealed that Pfizer agreed to pay Dr. Jarvik $1,350,000 as a celebrity pitchman for the heart drug Lipitor, and wants to know how much stunt doubles in the ads may have also been paid.

Celebrity advertising endorsements are nothing new, of course. But the Lipitor campaign is a rare instance of a well-known doctor's endorsing a drug in advertising - and it has helped rekindle a smoldering debate over whether it is appropriate to aim ads for prescription drugs directly at consumers.